A prospective study of the effect of dexmedetomidine on emergence delirium in pediatric patients undergoing laparoscopic surgerys

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300078756

Enrollment

Unknown

Registered

2023-12-18

Start date

2023-12-20

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

emergence delirium

Interventions

Dexmedetomidine group:Intravenous dexmedetomidine infusion

Normal saline group:Intravenous physiological saline infusion

Eligibility

Sex/Gender

All

Age

2 Years to 7 Years

Inclusion criteria

Inclusion criteria: 1, Age is 2-7 years old. Children undergoing laparoscopic surgery for inguinal hernia or hydrocele 2, ASA I-II 3, No history of surgery under general anesthesia 4, No sedative or analgesic drugs were used within 24 hours before surgery 5, No neurological disease

Exclusion criteria

Exclusion criteria: 1, Obvious abnormal functions of heart, lung, liver and kidney 2, Child patients with dexmedetomidine allergy 3, Intellectual disability or developmental delay 4, Disturbance of behavior 5, Their parents refused to participate

Design outcomes

Primary

Measure	Time frame
Incidence of Emergence delirium;CAPD score ;Pain score;rSO2;	—

Secondary

Measure	Time frame
Preoperative anxiety score;Systolic pressure, Diastolic blood pressure, mean arterial pressure;Heart rate;Emergence time;extubation time;PACU recovery time;Length of stay;	—

Countries

China

Contacts

Public ContactDongyi Tong

Shengjing Hospital of China Medical University

nadiatong@163.com+86 189 4025 8294

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026